Search

Your search keyword '"Triggiani, M."' showing total 961 results

Search Constraints

Start Over You searched for: Author "Triggiani, M." Remove constraint Author: "Triggiani, M."
961 results on '"Triggiani, M."'

Search Results

1. Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models

2. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

4. Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series

5. PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

6. PCR136 The Burden of Systemic Mastocytosis in Select European Countries: Evidence from the Prism Patient Survey

7. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

9. Targeted therapy in severe asthma today: focus on immunoglobulin E

10. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry

11. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

13. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

16. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

17. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

19. A Contribution to the Harmonization of Non-targeted NMR Methods for Data-Driven Food Authenticity Assessment

20. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

21. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

22. Work productivity in rhinitis using cell phones: The MASK pilot study

23. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

25. Innovative Approaches to Active and Healthy Ageing: Campania Experience to Improve the Adoption of Innovative Good Practices

26. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

27. Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis

28. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

29. Phenotypic and functional heterogeneity of low-density and high-density human lung macrophages. (VARRICCHI AUTORE CORRISPONDENTE)

30. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

31. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

33. Sécurité d’emploi de l’avapritinib dans la mastocytose systémique indolente (MSI) : suivi à plus long terme de l’étude PIONEER

34. Efficacité et sécurité d’emploi de l’avapritinib dans la mastocytose systémique indolente (MSI) : résultats de l’étude PIONEER en double aveugle, contrôlée par placebo

35. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

38. Severe asthma: One disease and multiple definitions

39. Cardiac surgery practice during the COVID-19 outbreak: A multicentre national survey

40. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

43. Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice

44. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

46. How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study

47. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

50. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

Catalog

Books, media, physical & digital resources